10 years of revenue, profit, cash flow and balance-sheet history through FY2026,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 16.6% per year over the past 5 years.
Operating margin has contracted, at -408.4% in the latest year.
Financial health
Total debt has grown faster than revenue (53.3% vs 16.6% per year).
Operating income covered interest expense -369.1× in the latest year.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2026
$2M
-$8M
27.8%
-408.4%
-123.2%
-109.0%
-$5M
—
$5M
2025
$2M
-$10M
34.7%
-480.7%
-163.1%
-140.3%
-$5M
—
$4M
2024
$2M
-$5M
41.3%
-233.6%
-85.2%
-73.0%
-$4M
—
$492942
2023
$2M
-$4M
36.1%
-215.2%
-52.3%
-47.4%
-$3M
—
$2M
2022
$1M
-$6M
39.0%
-429.7%
-52.1%
-48.5%
-$3M
—
$5M
2021
$943702
-$3M
33.5%
-275.1%
-41.2%
-29.5%
—
—
$151993
2020
$119364
-$3M
-360.0%
-1649.9%
-1551.4%
-123.8%
—
—
$10181
2019
$245285
-$3M
-17.5%
-1358.1%
-138.5%
-118.7%
-$1M
—
$474653
2018
—
-$3M
—
—
-2199.0%
-1620.4%
—
$16050
—
2017
—
-$151260
—
—
-654.6%
-400.9%
—
$10469
$27124
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jul '26
$437514
-$880561
41.6%
-203.6%
-16.5%
-14.0%
—
—
$3M
Apr '26
$433399
-$1M
45.4%
-289.4%
-20.7%
-18.0%
—
—
$4M
Jan '26
$400709
-$968059
22.2%
-254.8%
-14.5%
-12.8%
-$731830
—
$5M
Oct '25
$346058
-$4M
19.8%
-1121.3%
-51.3%
-46.0%
-$2M
—
$5M
Jul '25
$622452
-$2M
25.2%
-321.8%
-23.6%
-19.7%
-$1M
—
$7M
Apr '25
$667432
-$1M
37.8%
-211.8%
-27.2%
-22.6%
-$1M
—
$3M
Jan '25
$642379
-$6M
44.5%
-865.3%
-85.8%
-73.8%
-$1M
—
$4M
Oct '24
$645796
-$1M
29.6%
-220.9%
-12.1%
-10.9%
-$1M
—
$6M
Jul '24
$442830
-$2M
22.9%
-318.3%
-13.7%
-12.5%
-$2M
—
$7M
Apr '24
$408532
-$2M
40.3%
-462.5%
-14.2%
-12.5%
-$840121
—
$8M
Jan '24
$524613
-$2M
34.5%
-249.0%
-29.2%
-25.0%
-$767377
—
$492942
Oct '23
$427841
-$2M
37.3%
-402.8%
-30.8%
-20.6%
-$1M
—
$1M
Jul '23
$655928
-$829173
45.7%
-125.7%
-12.0%
-8.4%
-$995135
—
$2M
Apr '23
$476932
-$1M
46.6%
-213.4%
-13.2%
-11.7%
-$752488
—
$1M
Jan '23
$527535
-$2M
24.5%
-319.1%
-19.6%
-17.8%
-$824028
—
$2M
Oct '22
$618003
-$1M
43.4%
-173.4%
-11.1%
-10.1%
-$521715
—
$3M
Jul '22
$456149
-$1M
33.3%
-226.7%
-10.0%
-9.1%
-$932699
—
$3M
Apr '22
$477922
-$689989
41.9%
-143.5%
-6.2%
-5.8%
-$788060
—
$4M
Jan '22
$491890
-$4M
49.1%
-767.5%
-31.8%
-29.6%
-$1M
—
$5M
Oct '21
$283037
-$2M
26.6%
-543.5%
-11.0%
-10.2%
-$1M
—
$5M
Valuation over time
How the market has priced NTRB against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 19.7× (Mar '23) to 33.5× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is NTRB growing its revenue and profit?
Over the past 5 years, NutriBand Inc.'s revenue has grown 16.6% per year. These are computed facts, not advice.
How much debt does NTRB have?
As of FY2026, NutriBand Inc. reported — of total debt against $5M of cash; operating income covered interest expense -369.1×.
What is NTRB's profit margin?
In FY2026, gross margin was 27.8%, operating margin -408.4%, and net margin -404.1%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.